[Chronic autoimmune hemolytic anemia: toward new treatments?]

Arch Pediatr. 2006 Jun;13(6):517-9. doi: 10.1016/j.arcped.2006.03.007. Epub 2006 May 11.
[Article in French]
No abstract available

MeSH terms

  • Anemia, Hemolytic, Autoimmune / diagnosis
  • Anemia, Hemolytic, Autoimmune / immunology
  • Anemia, Hemolytic, Autoimmune / therapy*
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Murine-Derived
  • Antigens, CD20 / immunology
  • Biological Factors / adverse effects
  • Biological Factors / therapeutic use*
  • Bone Marrow Transplantation*
  • Child
  • Chronic Disease
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Erythrocyte Membrane / immunology
  • Follow-Up Studies
  • Humans
  • IMP Dehydrogenase / antagonists & inhibitors
  • Immunosuppressive Agents / adverse effects
  • Immunosuppressive Agents / therapeutic use*
  • Mycophenolic Acid / adverse effects
  • Mycophenolic Acid / analogs & derivatives*
  • Mycophenolic Acid / therapeutic use
  • Rituximab

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Murine-Derived
  • Antigens, CD20
  • Biological Factors
  • Immunosuppressive Agents
  • Rituximab
  • IMP Dehydrogenase
  • IMPDH1 protein, human
  • Mycophenolic Acid